Shuai Li

9PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapyPharmaceutical delivery technologiesTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 07, 2026
Targeted degradation of c-Myc through the midnolin-proteasome pathway.

Jingyuan Zhao, Huanhuan Wu, Han Yu

|Dec 03, 2025
Advances in Peptide-Based Chimeric Strategies for Targeted Protein Degradation.

Yixuan Wang, Jingyuan Zhao, Hong Yuan

|Nov 13, 2025
Strike Mitochondria By Enzyme-Instructed Self-Assembled Peptides for Effective Immunogenic Anti-Tumor Therapy.

Jingyuan Zhao, Siyu Tian, Pengfei Li

|Oct 13, 2025
Mitochondria-Targeting Antimicrobial Peptide (AMP) Regulating N6-Methyladenosine (m6A) Modification to Promote Colon Cancer Ferroptosis.

Chenyu Li, Shuai Li, Linlin Lv

|Oct 02, 2025
Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications.

Zhen Ren, Jingyuan Zhao, Shuai Li

|Jul 02, 2025
Advancements in Nano-Delivery Systems for Photodynamic and Photothermal Therapy to Induce Immunogenic Cell Death in Tumor Immunotherapy.

Rui Zhao, Shuai Li, Jingyuan Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Rui Zhao

1 joint publications

Zhen Ren

1 joint publications

Huanhuan Wu

1 joint publications

Han Yu